UBT251 Injection 2.0 mg and UBT251 Injection Placebo
TUL-UBT251(Ⅱ-2)202405
Phase 2 small_molecule completed
Quick answer
UBT251 Injection 2.0 mg and UBT251 Injection Placebo for Type 2 Diabetes Mellitus (T2DM) is a Phase 2 program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).
Program details
- Company
- UNITED THERAPEUTICS Corp
- Indication
- Type 2 Diabetes Mellitus (T2DM)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed